Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

almirall ag - mometasoni-17 furoas - crema - mometasoni-17 furoas 1 mg, aqua purificata, vaselinum album cum e 321 50 ppm, paraffinum liquidum, hexylene glycol, cetylanum 72 mg, macrogoli aether cetostearylicus, alcohol cetylicus 10 mg, glycerolum, acidum citricum, natrii citras dihydricus, xanthani gummi, ad unguentum pro 1 g. - non infetto, dermatosi infiammatoria - synthetika

Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - imiquimodum - crema - imiquimodum 37.5 mg, acidum isostearicum, alcohol benzylicus 20.0 mg, alcohol cetylicus 22.0 mg, alcohol stearylicus 31.0 mg, vaselinum album, polysorbatum 60, sorbitani stearas, glycerolum, xanthani gummi, e 218 2.0 mg, propylis parahydroxybenzoas 0.2 mg, aqua purificata, ad emulsionem pro 1 g. - cheratosi attinica (non hyperkeratotisch); second-line - synthetika

Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - clotrimazolum - kombi forte, 500 mg und 20 g 1% - i) vaginalkapseln: clotrimazolum 500.00 mg, vaselinum album, paraffinum liquidum, kapselhülle: gelatina, glycerolum, aqua purificata, e 171, e 104, e 110, lecithinum, triglycerida media, pro capsula. ii) creme: clotrimazolum 10 mg, alcohol benzylicus 20 mg, alcohol cetylicus et stearylicus 100 mg, cetylis palmitas, octyldodecanolum, polysorbatum 60, aqua purificata, sorbitani stearas, ad unguentum pro 1 g. - da clotrimazolo-patogeni sensibili provocato vulvovaginale infezioni - synthetika

Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - unguento grasso - vaselinum album, polysorbatum 80, macrogol 40 sorbitoli heptaoleas, macrogoli stearas. - intervallo - e post-trattamento di dermatosi, la tutela e la cura della pelle secca - synthetika

Італія - італійська - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - leuprolide - leuprolide

Європейський Союз - італійська - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - palbociclibum - capsule rigide - palbociclibum 75 mg, cellulosum microcristallinum, lactosum monohydricum 55.775 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.28 mg. - carcinoma della mammella - synthetika

Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - palbociclibum - capsule rigide - palbociclibum 100 mg, cellulosum microcristallinum, lactosum monohydricum 74.367 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 1.71 mg. - carcinoma della mammella - synthetika

Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - palbociclibum - capsule rigide - palbociclibum 125 mg, cellulosum microcristallinum, lactosum monohydricum 92.958 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 172 (rubrum), e 172 (flavum), e 171, drucktinte: lacca, e 171, ammoniae solutio 28 per centum, propylenglycolum, simeticonum, pro capsula, natrium 2.13 mg. - carcinoma della mammella - synthetika

Італія - італійська - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - bicalutamide - bicalutamide